Media Center

 

Third Rock News & Events

January 26, 2017 - Third Rock Ventures Names Sarah Larson as Partner
» Read More

October 31, 2016 - Third Rock Ventures Raises $616 Million Fund IV
» Read More

September 24, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to receive the Henri Termeer Lifetime Achievement Award at the 5th Annual Tribute to Champions of Hope
» Read More

May 23, 2016 - Third Rock Ventures’ Venture Partner Phil Reilly to Speak at MassBio Event to Discuss his New Book “Orphan: The Quest to Save Children with Rare Disease”
» Read More

April 25, 2016 - Third Rock Ventures' Partner, Robert Tepper, to Moderate Panel at the World Medical Innovation Forum
» Read More

April 6, 2016 - Third Rock Ventures' Partner, Cary Pfeffer, to Present at Xconomy's EXOME: What's Hot in Boston Biotech
» Read More

Portfolio News

bluebird bio
June 15, 2018 - bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association
» Press Release | Company News

bluebird bio
June 15, 2018 - bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association
» Press Release | Company News

Blueprint Medicines
June 15, 2018 - Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity
» Press Release | Company News

Global Blood Therapeutics
June 15, 2018 - GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
» Press Release | Company News

CytomX Therapeutics
June 14, 2018 - CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel
» Press Release | Company News

Rhythm Pharmaceuticals
June 14, 2018 - Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
» Press Release | Company News

SAGE Therapeutics
June 13, 2018 - Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea
» Press Release | Company News

Editas Medicine
June 13, 2018 - Editas Medicine to Participate in The JMP Securities Life Sciences Conference
» Press Release | Company News

SAGE Therapeutics
June 12, 2018 - Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meeting
» Press Release | Company News

Allena Pharmaceuticals
June 11, 2018 - Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors
» Press Release | Company News

News Archives